On ECHEMI
Home > Drugs > Aimei Chengxin Biopharmaceutical Co., Ltd.
Aimei Chengxin Biopharmaceutical Co., Ltd.
  • Founded in:

    1993-09-20
  • Country:

    China China
  • Address:

    1-3F, No. 35-4, Wanda Road, Dalian Economic and Technological Development Zone, China (Liaoning) Pilot Free Trade Zone
  • Tax NO.:

    91210213241314449J
  • Registered Funds:

    250 million yuan
  • Website:

  • Email:

Related Drugs
Human rabies vaccine (hamster kidney cells)
Name Description Content CAS NO. Registered Holders
Human rabies vaccine (hamster kidney cells)

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Influenza virus split vaccine
The composition of this vaccine is in line with the strains recommended by WHO for the current year. Each dose of vaccine contains three strains of antigens: type A1, type A3, and type B. Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) Hemagglutinin content: ge; 12mu; g Type A3 (Fujian/41I/02 (H3N2) similar strain [NYMCX-147 strain]) Hemagglutinin content: ge; 12mu; g Type B (B/Shanghai/36I/02 similar strain [B/Jiangsu/10/2003 strain]) Hemagglutinin content: ge; 12mu; g
Name Description Content CAS NO. Registered Holders
Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain])

Inducing immune response to prevent influenza virus infection

More

Inducing immune response to prevent influenza virus infection

≥12μg 0
Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain])

Inducing immune response to prevent influenza virus infection

More

Inducing immune response to prevent influenza virus infection

≥12μg 0
Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003])

Inducing immune response to prevent influenza virus infection

More

Inducing immune response to prevent influenza virus infection

≥12μg 0
Recombinant Hepatitis B Vaccine (Hansenula)
This product is made by purifying the hepatitis B virus surface antigen (HBsAg) expressed by recombinant Hansen yeast and adsorbing it with aluminum adjuvant. It is a milky white suspension liquid that can be separated by precipitation and is easy to shake. The main ingredient is hepatitis B surface antigen; the auxiliary materials include aluminum hydroxide and sodium chloride.
Name Description Content CAS NO. Registered Holders
HBSAG

Induce immunity against hepatitis B virus

More

Induce immunity against hepatitis B virus

0
Related Indication
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.